Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular Carcinoma |
| |
| Affiliation: | 1. Department of Metabolic Center, Texas Liver Institute, San Antonio, Texas;3. Institute for Gastrointestinal and Liver Disease, Shin-Yurigaoka General Hospital, Kawasaki, Japan;4. Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan;5. Biostatistics Center, Shionogi & Co, Ltd, Osaka, Japan;7. Global Market Access, Shionogi, Inc, Florham Park, New Jersey;12. Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy |
| |
| Abstract: | ![]()
|
| |
| Keywords: | Hepatocellular Carcinoma Chronic Liver Disease Thrombopoietin Receptor Agonist Invasive Procedure CLD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0045" }," $$" :[{" #name" :" text" ," _" :" chronic liver disease HCC" },{" #name" :" keyword" ," $" :{" id" :" kwrd0055" }," $$" :[{" #name" :" text" ," _" :" hepatocellular carcinoma PP" },{" #name" :" keyword" ," $" :{" id" :" kwrd0075" }," $$" :[{" #name" :" text" ," _" :" per-protocol PVT" },{" #name" :" keyword" ," $" :{" id" :" kwrd0085" }," $$" :[{" #name" :" text" ," _" :" portal vein thrombosis TCP-CLD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0095" }," $$" :[{" #name" :" text" ," _" :" thrombocytopenia associated with chronic liver disease TEAE" },{" #name" :" keyword" ," $" :{" id" :" kwrd0105" }," $$" :[{" #name" :" text" ," _" :" treatment-emergent adverse event TPO-RA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0115" }," $$" :[{" #name" :" text" ," _" :" thrombopoietin receptor agonist |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
